Richard A Goodman1, Kimberly A Lochner2, Madhav Thambisetty3, Thomas S Wingo4, Samuel F Posner5, Shari M Ling2. 1. National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Prevention and Control, Atlanta, GA, USA; Department of Family and Preventive Medicine, Emory University School of Medicine, Atlanta, GA, USA. Electronic address: rgood02@emory.edu. 2. Centers for Medicare & Medicaid Services, Baltimore, MD, USA. 3. Clinical and Translational Neuroscience Unit, Laboratory of Behavioral Neuroscience, National Institute on Aging, National Institutes of Health, Baltimore, MD, USA. 4. Department of Neurology and Human Genetics, Emory University School of Medicine, Atlanta, GA, USA; Division of Neurology, Atlanta VA Medical Center, Atlanta, GA, USA. 5. National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Prevention and Control, Atlanta, GA, USA.
Abstract
INTRODUCTION: Rapid growth of the older adult population requires greater epidemiologic characterization of dementia. We developed national prevalence estimates of diagnosed dementia and subtypes in the highest risk United States (US) population. METHODS: We analyzed Centers for Medicare & Medicaid administrative enrollment and claims data for 100% of Medicare fee-for-service beneficiaries enrolled during 2011-2013 and age ≥68 years as of December 31, 2013 (n = 21.6 million). RESULTS: Over 3.1 million (14.4%) beneficiaries had a claim for a service and/or treatment for any dementia subtype. Dementia not otherwise specified was the most common diagnosis (present in 92.9%). The most common subtype was Alzheimer's (43.5%), followed by vascular (14.5%), Lewy body (5.4%), frontotemporal (1.0%), and alcohol induced (0.7%). The prevalence of other types of diagnosed dementia was 0.2%. DISCUSSION: This study is the first to document concurrent prevalence of primary dementia subtypes among this US population. The findings can assist in prioritizing dementia research, clinical services, and caregiving resources.
INTRODUCTION: Rapid growth of the older adult population requires greater epidemiologic characterization of dementia. We developed national prevalence estimates of diagnosed dementia and subtypes in the highest risk United States (US) population. METHODS: We analyzed Centers for Medicare & Medicaid administrative enrollment and claims data for 100% of Medicare fee-for-service beneficiaries enrolled during 2011-2013 and age ≥68 years as of December 31, 2013 (n = 21.6 million). RESULTS: Over 3.1 million (14.4%) beneficiaries had a claim for a service and/or treatment for any dementia subtype. Dementia not otherwise specified was the most common diagnosis (present in 92.9%). The most common subtype was Alzheimer's (43.5%), followed by vascular (14.5%), Lewy body (5.4%), frontotemporal (1.0%), and alcohol induced (0.7%). The prevalence of other types of diagnosed dementia was 0.2%. DISCUSSION: This study is the first to document concurrent prevalence of primary dementia subtypes among this US population. The findings can assist in prioritizing dementia research, clinical services, and caregiving resources.
Authors: Denis A Evans; David A Bennett; Robert S Wilson; Julia L Bienias; Martha Clare Morris; Paul A Scherr; Liesi E Hebert; Neelum Aggarwal; Laurel A Beckett; Rajiv Joglekar; Elizabeth Berry-Kravis; Julie Schneider Journal: Arch Neurol Date: 2003-02
Authors: Rodolfo Savica; Brandon R Grossardt; James H Bower; Bradley F Boeve; J Eric Ahlskog; Walter A Rocca Journal: JAMA Neurol Date: 2013-11 Impact factor: 18.302
Authors: Cyndy B Cordell; Soo Borson; Malaz Boustani; Joshua Chodosh; David Reuben; Joe Verghese; William Thies; Leslie B Fried Journal: Alzheimers Dement Date: 2012-12-20 Impact factor: 21.566
Authors: Yingjia Chen; Leslie Wilson; John Kornak; R Adams Dudley; Jennifer Merrilees; Stephen J Bonasera; Christie M Byrne; Kirby Lee; Winston Chiong; Bruce L Miller; Katherine L Possin Journal: Alzheimers Dement Date: 2019-06-04 Impact factor: 21.566
Authors: Ashley F Curtis; Mario Masellis; Ging-Yuek Robin Hsiung; Rahim Moineddin; Kathy Zhang; Bonnie Au; Geneva Millett; Ian Mackenzie; Ekaterina Rogaeva; Mary C Tierney Journal: Neurology Date: 2017-09-15 Impact factor: 9.910
Authors: Ganesh M Babulal; Yakeel T Quiroz; Benedict C Albensi; Eider Arenaza-Urquijo; Arlene J Astell; Claudio Babiloni; Alex Bahar-Fuchs; Joanne Bell; Gene L Bowman; Adam M Brickman; Gaël Chételat; Carrie Ciro; Ann D Cohen; Peggye Dilworth-Anderson; Hiroko H Dodge; Simone Dreux; Steven Edland; Anna Esbensen; Lisbeth Evered; Michael Ewers; Keith N Fargo; Juan Fortea; Hector Gonzalez; Deborah R Gustafson; Elizabeth Head; James A Hendrix; Scott M Hofer; Leigh A Johnson; Roos Jutten; Kerry Kilborn; Krista L Lanctôt; Jennifer J Manly; Ralph N Martins; Michelle M Mielke; Martha Clare Morris; Melissa E Murray; Esther S Oh; Mario A Parra; Robert A Rissman; Catherine M Roe; Octavio A Santos; Nikolaos Scarmeas; Lon S Schneider; Nicole Schupf; Sietske Sikkes; Heather M Snyder; Hamid R Sohrabi; Yaakov Stern; Andre Strydom; Yi Tang; Graciela Muniz Terrera; Charlotte Teunissen; Debora Melo van Lent; Michael Weinborn; Linda Wesselman; Donna M Wilcock; Henrik Zetterberg; Sid E O'Bryant Journal: Alzheimers Dement Date: 2018-12-13 Impact factor: 21.566
Authors: David C Goff; Denis B Buxton; Gail D Pearson; Gina S Wei; Teri E Gosselin; Ebyan A Addou; Catherine M Stoney; Patrice Desvigne-Nickens; Pothur R Srinivas; Zorina S Galis; Charlotte Pratt; Kit Brian K Kit; Christine Maric-Bilkan; Holly L Nicastro; Renee P Wong; Vandana Sachdev; Jue Chen; Lawrence Fine Journal: Circ Res Date: 2019-02-15 Impact factor: 17.367
Authors: Paul L Kimmel; Chyng-Wen Fwu; Kevin C Abbott; Marva M Moxey-Mims; Susan Mendley; Jenna M Norton; Paul W Eggers Journal: Clin J Am Soc Nephrol Date: 2019-08-22 Impact factor: 8.237
Authors: Kevin A Matthews; Wei Xu; Anne H Gaglioti; James B Holt; Janet B Croft; Dominic Mack; Lisa C McGuire Journal: Alzheimers Dement Date: 2018-09-19 Impact factor: 21.566
Authors: Igor Akushevich; Arseniy P Yashkin; Julia Kravchenko; Svetlana Ukraintseva; Eric Stallard; Anatoliy I Yashin Journal: J Alzheimers Dis Date: 2018 Impact factor: 4.472